| A metallo-DNA nanowire with uninterrupted one-dimensional silver array J Kondo, Y Tada, T Dairaku, Y Hattori, H Saneyoshi, A Ono, Y Tanaka Nature chemistry 9 (10), 956-960, 2017 | 207 | 2017 |
| Interferon-γ activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells Y Kuwano, T Kawahara, H Yamamoto, S Teshima-Kondo, K Tominaga, ... American Journal of Physiology-Cell Physiology 290 (2), C433-C443, 2006 | 144 | 2006 |
| Cryo-EM structure of a dimeric B-Raf: 14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases Y Kondo, J Ognjenović, S Banerjee, D Karandur, A Merk, K Kulhanek, ... Science 366 (6461), 109-115, 2019 | 141 | 2019 |
| Worldmaking: Race, performance, and the work of creativity D Kondo Duke University Press, 2018 | 137 | 2018 |
| The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples R Bonar, EJ Favaloro, S Mohammed, M Ahuja, L Pasalic, J Sioufi, ... Pathology 48 (1), 60-71, 2016 | 119 | 2016 |
| How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents for … EJ Favaloro, G Kershaw, S Mohammed, G Lippi Seminars in thrombosis and hemostasis 45 (01), 022-035, 2019 | 105 | 2019 |
| Evaluating errors in the laboratory identification of von Willebrand disease in the real world EJ Favaloro, RA Bonar, M Meiring, E Duncan, S Mohammed, J Sioufi, ... umatislam.com 134 (2), 393-403, 2014 | 86 | 2014 |
| The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples R Bonar, EJ Favaloro, S Mohammed, J Sioufi, K Marsden Pathology 47 (4), 355-364, 2015 | 79 | 2015 |
| A laboratory evaluation into the short activated partial thromboplastin time A Mina, EJ Favaloro, S Mohammed, J Koutts Blood coagulation & fibrinolysis 21 (2), 152-157, 2010 | 75 | 2010 |
| Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease EJ Favaloro, S Mohammed Thrombosis Research 141, 202-211, 2016 | 68 | 2016 |
| Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays EJ Favaloro, S Mohammed Thrombosis Research 134 (6), 1292-1300, 2014 | 68 | 2014 |
| Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives EJ Favaloro, S Mohammed, J Curnow, L Pasalic Pathology 51 (3), 292-300, 2019 | 62 | 2019 |
| Enhanced electrochemical response in oxidative differential pulse voltammetry of dopamine in the presence of ascorbic acid at carboxyl-terminated boron-doped diamond electrodes T Kondo, Y Niwano, A Tamura, J Imai, K Honda, Y Einaga, DA Tryk, ... umatislam.com 54 (8), 2312-2319, 2009 | 62 | 2009 |
| Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): a comparative study using DOAC Stop and andexanet alfa EJ Favaloro, G Gilmore, S Arunachalam, S Mohammed, R Baker Thrombosis Research 180, 10-19, 2019 | 57 | 2019 |
| Type 2M von Willebrand disease–more often misidentified than correctly identified EJ Favaloro, RA Bonar, S Mohammed, A Arbelaez, J Niemann, R Freney, ... Haemophilia 22 (3), e145-e155, 2016 | 47 | 2016 |
| HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia EJ Favaloro, G McCaughan, S Mohammed, KKE Lau, R Gemmell, ... Pathology 50 (4), 426-436, 2018 | 46 | 2018 |
| Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia EJ Favaloro, S Mohammed, J Koutts Blood coagulation & fibrinolysis 20 (8), 706-714, 2009 | 41 | 2009 |
| Migraine aura: pathophysiology, mimics, and treatment options CL Fraser, JL Hepschke, B Jenkins, S Prasad Seminars in Neurology 39 (06), 739-748, 2019 | 40 | 2019 |
| Transcranial direct current stimulation does not affect lower extremity muscle strength training in healthy individuals: a triple-blind, sham-controlled study K Maeda, T Yamaguchi, T Tatemoto, K Kondo, Y Otaka, S Tanaka Frontiers in neuroscience 11, 179, 2017 | 38 | 2017 |
| A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity EJ Favaloro, S Mohammed, K Chapman, P Swanepoel, D Zebeljan, ... Journal of Thrombosis and Haemostasis 19 (2), 417-428, 2021 | 34 | 2021 |
